Logo

Crossref


1. Research Progress on Anti-VEGF Drug Ther-apy for Retinopathy of Prematurity

-

2. Retinopathy prematurity: a systematic review and meta-analysis study based on neonatal and maternal risk factors

- Tahereh Bahmani

- Arezoo Karimi

- Nazanin Rezaei

- Salman Daliri

3. Biomarkers in retinopathy of prematurity: a systematic review and meta-analysis

- Mariam Almutairi

- Katherine Chechalk

- Emelia Deane

- Rebecca Fox

- Ava Janes

- Tidgh Maguire-Henry

- Devin McCabe

- Cole O'Connor

- Joseph Quirk

- Evan Swan

- Katherine White

- Kathryn McCreery

- Eman Isweisi

- Philip Stewart

- Aoife Branagan

- Edna F. Roche

- Judith Meehan

- Eleanor J. Molloy

4. Risk Factors of Retinopathy of Prematurity Associated with Delayed Retinal Vascular Development

- Jose Maria Ortega-Molina

- Solans-Perez de Larraya A.

- Salgado-Miranda A.

- Jerez-Calero A.

- Uberos-Fernandez J.

- Gonzalez Ramirez A. R.

- Jose Luis Garcia-Serrano

5. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review

- Yogavijayan Kandasamy

- Leo Hartley

- Donna Rudd

- Roger Smith

6. Umbilical Blood Levels of IL-6 and TNF-α as Predictors of the Central Nervous System Damage and Retinopathy in Preterm Infants

- Daiva Bartkevičienė

- Ingrida Pilypienė

- Danielius Serapinas

- Brigita Vaigauskaitė

- Rasa Aurelija Vankevičiūtė

- Agnė Bartkevičiūtė

- Ieva Narkevičiūtė

- Irena Dumalakienė

7. Retinopathy of prematurity: a review of risk factors and their clinical significance

- Sang Jin Kim

- Alexander D. Port

- Ryan Swan

- J. Peter Campbell

- R.V. Paul Chan

- Michael F. Chiang